omniture
logo
Search
PHARMABCINE INC
Media Room

Latest News

rss

PharmAbcine Announces Last Patient Last Visit in its Phase Ib mTNBC Combination Trial

DAEJEON, South Korea, Feb. 25, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical...

2022-02-25 21:00 2328

PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody

DAEJEON, South Korea, Oct. 19, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical...

2021-10-19 20:00 1349

PharmAbcine to Participate in BIO-Europe 2021

DAEJEON, South Korea, Sept. 20, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinica...

2021-09-20 20:00 1333

PharmAbcine to Participate in ACCESS CHINA Biotech Forum

DAEJEON, South Korea, Sept. 13, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinica...

2021-09-13 20:00 1242

PharmAbcine Announces Joint Patent Application with MSD for the Treatment of Cancer

DAEJEON, South Korea, Sept. 9, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical...

2021-09-09 20:00 1629

PharmAbcine Receives HREC Clearance for Phase II Trial of Olinvacimab and Pembrolizumab in mTNBC

DAEJEON, South Korea, Sept. 3, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical...

2021-09-03 20:00 1843

PharmAbcine to Participate in H.C. Wainright 23rd Annual Global Investment Conference

DAEJEON, South Korea, Aug. 23, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical...

2021-08-23 20:00 1390

PharmAbcine Announces Submission of PCT for an Anti-ANG2 Antibody for the Treatment of Ocular Diseases

DAEJEON, South Korea, Aug. 19, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical...

2021-08-19 20:00 1224

PharmAbcine to Participate in Biotechgate Digital Partnering

DAEJEON, South Korea, Aug. 17, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical...

2021-08-17 20:00 1252

PharmAbcine to Present at H.C Wainwright Ophthalmology Virtual Conference

DAEJEON, South Korea, July 26, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical...

2021-07-26 20:00 1447

PharmAbcine to Present at the BIO Digital International Convention 2021

DAEJEON, South Korea, June 2, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-...

2021-06-02 20:00 2281

PharmAbcine Announces Encouraging Non-clinical Data of PMC-403 at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting

DAEJEON, South Korea, May 10, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-...

2021-05-10 20:00 1439

PharmAbcine to Present at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting

DAEJEON, South Korea, April 26, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinica...

2021-04-26 20:00 1591

PharmAbcine announces Clinical Trial Collaboration with MSD for the Phase II study in mTNBC

DAEJEON, South Korea, April 19, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinica...

2021-04-19 20:00 1502

PharmAbcine presents the non-clinical data of PMC-309 at AACR 2021

DAEJEON, South Korea, April 12, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinica...

2021-04-12 20:00 1474

PharmAbcine to Present at AACR Annual Meeting 2021

DAEJEON, South Korea, March 11, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinica...

2021-03-11 21:00 1448

PharmAbcine announces a research collaboration with LegoChem Biosciences

DAEJEON, South Korea, Jan. 11, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical...

2021-01-11 21:00 1187

PharmAbcine to participate in BIO @ JPM and Biotech Showcase Digital during "J.P. Morgan Week 2021"

DAEJEON, South Korea, Jan. 4, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-...

2021-01-04 21:00 1682

PharmAbcine presents the latest data of the ongoing Phase Ib mTNBC trial at SABCS 2020

DAEJEON, South Korea, Dec. 9, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-...

2020-12-09 23:00 1471

PharmAbcine to present new interim data from its ongoing mTNBC trial at SABCS 2020

DAEJEON, South Korea, Dec. 7, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-...

2020-12-07 21:00 1231
123